284 related articles for article (PubMed ID: 29408481)
21. High expression of microRNA-4295 contributes to cell proliferation and invasion of pancreatic ductal adenocarcinoma by the down-regulation of Glypican-5.
Yuan Q; Zhang Y; Li J; Cao G; Yang W
Biochem Biophys Res Commun; 2018 Feb; 497(1):73-79. PubMed ID: 29407175
[TBL] [Abstract][Full Text] [Related]
22. Tumor suppressive role of miR-33a-5p in pancreatic ductal adenocarcinoma cells by directly targeting RAP2A.
Lian Y; Jiang D; Sun J
Cell Mol Biol Lett; 2021 Jun; 26(1):24. PubMed ID: 34090323
[TBL] [Abstract][Full Text] [Related]
23. ZFP36L2 promotes cancer cell aggressiveness and is regulated by antitumor microRNA-375 in pancreatic ductal adenocarcinoma.
Yonemori K; Seki N; Kurahara H; Osako Y; Idichi T; Arai T; Koshizuka K; Kita Y; Maemura K; Natsugoe S
Cancer Sci; 2017 Jan; 108(1):124-135. PubMed ID: 27862697
[TBL] [Abstract][Full Text] [Related]
24. Exosomes secreted from human umbilical cord mesenchymal stem cells promote pancreatic ductal adenocarcinoma growth by transferring miR-100-5p.
Ding Y; Mei W; Zheng Z; Cao F; Liang K; Jia Y; Wang Y; Liu D; Li J; Li F
Tissue Cell; 2021 Dec; 73():101623. PubMed ID: 34543801
[TBL] [Abstract][Full Text] [Related]
25. Identifying a novel IRF3/circUHRF1/miR-1306-5p/ARL4C axis in pancreatic ductal adenocarcinoma progression.
Liu W; Deng L; Xu A; Xiong X; Tao J; Chang J; Xu Y; Zhou Z
Cell Cycle; 2022 Feb; 21(4):392-405. PubMed ID: 34983293
[TBL] [Abstract][Full Text] [Related]
26. Role of miR-214-5p in the migration and invasion of pancreatic cancer cells.
Cao TH; Ling X; Chen C; Tang W; Hu DM; Yin GJ
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7214-7221. PubMed ID: 30468464
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4.
Xia X; Zhang K; Cen G; Jiang T; Cao J; Huang K; Huang C; Zhao Q; Qiu Z
Oncotarget; 2015 Aug; 6(25):21046-63. PubMed ID: 26019136
[TBL] [Abstract][Full Text] [Related]
28. Circular RNA ciRS-7 promotes the proliferation and metastasis of pancreatic cancer by regulating miR-7-mediated EGFR/STAT3 signaling pathway.
Liu L; Liu FB; Huang M; Xie K; Xie QS; Liu CH; Shen MJ; Huang Q
Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):580-586. PubMed ID: 30898507
[TBL] [Abstract][Full Text] [Related]
29. HnRNPK/miR-223/FBXW7 feedback cascade promotes pancreatic cancer cell growth and invasion.
He D; Huang C; Zhou Q; Liu D; Xiong L; Xiang H; Ma G; Zhang Z
Oncotarget; 2017 Mar; 8(12):20165-20178. PubMed ID: 28423622
[TBL] [Abstract][Full Text] [Related]
30. MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3.
Chang W; Liu M; Xu J; Fu H; Zhou B; Yuan T; Chen P
Tumour Biol; 2016 Nov; 37(11):14813-14824. PubMed ID: 27638830
[TBL] [Abstract][Full Text] [Related]
31. miR-545 inhibited pancreatic ductal adenocarcinoma growth by targeting RIG-I.
Song B; Ji W; Guo S; Liu A; Jing W; Shao C; Li G; Jin G
FEBS Lett; 2014 Nov; 588(23):4375-81. PubMed ID: 25315416
[TBL] [Abstract][Full Text] [Related]
32. Exosomes derived from human umbilical cord mesenchymal stromal cells deliver exogenous miR-145-5p to inhibit pancreatic ductal adenocarcinoma progression.
Ding Y; Cao F; Sun H; Wang Y; Liu S; Wu Y; Cui Q; Mei W; Li F
Cancer Lett; 2019 Feb; 442():351-361. PubMed ID: 30419348
[TBL] [Abstract][Full Text] [Related]
33. MiR-17-5p enhances pancreatic cancer proliferation by altering cell cycle profiles via disruption of RBL2/E2F4-repressing complexes.
Zhu Y; Gu J; Li Y; Peng C; Shi M; Wang X; Wei G; Ge O; Wang D; Zhang B; Wu J; Zhong Y; Shen B; Chen H
Cancer Lett; 2018 Jan; 412():59-68. PubMed ID: 28987387
[TBL] [Abstract][Full Text] [Related]
34. Impact of Oncogenic Targets Controlled by Tumor-Suppressive
Nepal P; Hozaka Y; Tanaka T; Wada M; Asai S; Minemura C; Idichi T; Arigami T; Kurahara H; Seki N; Ohtsuka T
Anticancer Res; 2021 Oct; 41(10):4821-4836. PubMed ID: 34593431
[TBL] [Abstract][Full Text] [Related]
35. WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC.
Pan Y; Lu F; Xiong P; Pan M; Zhang Z; Lin X; Pan M; Huang H
J Exp Clin Cancer Res; 2018 Jul; 37(1):167. PubMed ID: 30041660
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-135a inhibits cell proliferation by targeting Bmi1 in pancreatic ductal adenocarcinoma.
Dang Z; Xu WH; Lu P; Wu N; Liu J; Ruan B; Zhou L; Song WJ; Dou KF
Int J Biol Sci; 2014; 10(7):733-45. PubMed ID: 25013381
[TBL] [Abstract][Full Text] [Related]
37. The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS.
Zhao WG; Yu SN; Lu ZH; Ma YH; Gu YM; Chen J
Carcinogenesis; 2010 Oct; 31(10):1726-33. PubMed ID: 20675343
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma.
Zhao C; Zhang J; Zhang S; Yu D; Chen Y; Liu Q; Shi M; Ni C; Zhu M
Oncol Rep; 2013 Jul; 30(1):276-84. PubMed ID: 23612862
[TBL] [Abstract][Full Text] [Related]
39. Biological Effect and Mechanism of the miR-23b-3p/ANXA2 Axis in Pancreatic Ductal Adenocarcinoma.
Wei DM; Dang YW; Feng ZB; Liang L; Zhang L; Tang RX; Chen ZM; Yu Q; Wei YC; Luo DZ; Chen G
Cell Physiol Biochem; 2018; 50(3):823-840. PubMed ID: 30355917
[TBL] [Abstract][Full Text] [Related]
40. miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-β signalling pathway.
Zhu Z; Xu Y; Zhao J; Liu Q; Feng W; Fan J; Wang P
Br J Cancer; 2015 Apr; 112(8):1367-75. PubMed ID: 25867271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
